Inter
NASDAQ: ICPT
128.78
+ 0.34 (0.27%)
4:00 PM ET on Jul 25, 2017
Delayed at least 20 minutes.

Recent Press Releases

Jun 22, 2017
Intercept's Ocaliva® (obeticholic acid) Receives 2017 Galien Chemical Synthesis Drug Award in Italy
Jun 12, 2017
Intercept Announces New Data Analysis From FLINT Trial of OCA in NASH Patients with Type 2 Diabetes
View all press releases >

Recent Events & Presentations

Jul 31, 2017 at 8:30 AM ET
Second Quarter 2017 Financial Results and Conference Call
View all events & presentations >
Corporate Governance >
Financial Information >
Stock Information >
Investor FAQs >
Contact Us >

10 Hudson Yards, 37th Floor | New York, NY 10001 | T: 844-782-ICPT
© 2017 Intercept Pharmaceuticals, Inc.